Back
Speaker illustration

Doctor Sara Rodrigues De Oliveira Siqueira

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

Member of:

Heart Failure Association of the ESC

Presentations

Influence of achieved LVEF on efficacy of dapagliflozin in patients with heart failure with improved ejection fraction: the DELIVER trial

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - epidemiology, prognosis, outcome 3

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources